About This Event

embecta Corp. (embecta) (Nasdaq: EMBC), a global diabetes care company, visits the Nasdaq MarketSite in Times Square today in recognition of National Diabetes Awareness Month in November.

embecta generates $1.1B in annual revenue. embecta’s history in the diabetes care category dates back to 1924 and the development of the world's first specialized insulin syringe. Today, it is a leading producer of insulin injection devices, manufacturing approximately 8 billion insulin syringes and pen needles annually for about 30 million people across more than 100 countries.

In honor of the occasion, Devdatt “Dev” Kurdikar, CEO of embecta, will be joined by representatives of the diabetes community to ring the Closing Bell.